Cande V Ananth1, Anthony M Vintzileos. 1. Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street, New Brunswick NJ 08901-1977, USA. cande.ananth@umdnj.edu
Abstract
BACKGROUND: Small for gestational age (SGA) can occur following a pathological process or may represent constitutionally small fetuses. However, distinguishing these processes is often difficult, especially in large studies, where the term SGA is often used as a proxy for restricted fetal growth. Since biologic variation in fetal size is largely a third trimester phenomenon, we hypothesized that the definition of SGA at term may include a sizeable proportion of constitutionally small fetuses. In contrast, since biologic variation in fetal size is not fully expressed in (early) preterm gestations, it is plausible that SGA in early preterm gestations would comprise a large proportion of growth restricted fetuses. AIM: We compared mortality and morbidity rates between SGA and appropriate for gestational age (AGA) babies. SUBJECTS: A population-based study of over 19million non-malformed, singleton births (1995-04) in the United States was performed. Gestational age (24-44weeks) was based on a clinical estimate. SGA and AGA were defined as sex-specific birthweight <10th and 25-74th centiles, respectively, for gestational age. All analyses were adjusted for a variety of confounding factors. OUTCOME MEASURES: Excess mortality risk in SGA and AGA babies. RESULTS: On an additive scale, stillbirth and neonatal mortality rates were higher at every preterm gestation among SGA than AGA births, and similar at term gestations. An inverse relationship between gestational age and excess deaths between SGA and AGA babies delivered at <37weeks was evident. CONCLUSIONS: In early preterm gestations, the definition of SGA may well be justified as a proxy for IUGR. In contrast, SGA babies that are delivered at term are likely to be constitutionally small.
BACKGROUND: Small for gestational age (SGA) can occur following a pathological process or may represent constitutionally small fetuses. However, distinguishing these processes is often difficult, especially in large studies, where the term SGA is often used as a proxy for restricted fetal growth. Since biologic variation in fetal size is largely a third trimester phenomenon, we hypothesized that the definition of SGA at term may include a sizeable proportion of constitutionally small fetuses. In contrast, since biologic variation in fetal size is not fully expressed in (early) preterm gestations, it is plausible that SGA in early preterm gestations would comprise a large proportion of growth restricted fetuses. AIM: We compared mortality and morbidity rates between SGA and appropriate for gestational age (AGA) babies. SUBJECTS: A population-based study of over 19million non-malformed, singleton births (1995-04) in the United States was performed. Gestational age (24-44weeks) was based on a clinical estimate. SGA and AGA were defined as sex-specific birthweight <10th and 25-74th centiles, respectively, for gestational age. All analyses were adjusted for a variety of confounding factors. OUTCOME MEASURES: Excess mortality risk in SGA and AGA babies. RESULTS: On an additive scale, stillbirth and neonatal mortality rates were higher at every preterm gestation among SGA than AGA births, and similar at term gestations. An inverse relationship between gestational age and excess deaths between SGA and AGA babies delivered at <37weeks was evident. CONCLUSIONS: In early preterm gestations, the definition of SGA may well be justified as a proxy for IUGR. In contrast, SGA babies that are delivered at term are likely to be constitutionally small.
Authors: Marianna Faraci; Eliana Renda; Santo Monte; Fosca A F Di Prima; Oriana Valenti; Roberta De Domenico; Elsa Giorgio; Entela Hyseni Journal: J Prenat Med Date: 2011-04
Authors: Sarah J Pugh; Paul S Albert; Sungduk Kim; William Grobman; Stefanie N Hinkle; Roger B Newman; Deborah A Wing; Katherine L Grantz Journal: Am J Obstet Gynecol Date: 2017-05-11 Impact factor: 8.661
Authors: Miguel Angel Luque-Fernandez; Cande V Ananth; Vincent W V Jaddoe; Romy Gaillard; Paul S Albert; Michael Schomaker; Patrick McElduff; Daniel A Enquobahrie; Bizu Gelaye; Michelle A Williams Journal: Eur J Epidemiol Date: 2015-01-29 Impact factor: 8.082
Authors: Samrawit F Yisahak; Stefanie N Hinkle; Sunni L Mumford; Mengying Li; Victoria C Andriessen; Katherine L Grantz; Cuilin Zhang; Jagteshwar Grewal Journal: Int J Epidemiol Date: 2021-03-03 Impact factor: 7.196
Authors: Holly C Groom; Ning Smith; Stephanie A Irving; Padma Koppolu; Gabriela Vazquez-Benitez; Elyse O Kharbanda; Matthew F Daley; James G Donahue; Darios Getahun; Lisa A Jackson; Nicola P Klein; Natalie L McCarthy; James D Nordin; Lakshmi Panagiotakopoulos; Allison L Naleway Journal: Vaccine Date: 2019-09-20 Impact factor: 3.641
Authors: Alexander C Ewing; Sascha R Ellington; Carrie K Shapiro-Mendoza; Wanda D Barfield; Athena P Kourtis Journal: Matern Child Health J Date: 2017-04
Authors: Yi Ying Ong; Suresh Anand Sadananthan; Izzuddin M Aris; Mya Thway Tint; Wen Lun Yuan; Jonathan Y Huang; Yiong Huak Chan; Sharon Ng; See Ling Loy; Sendhil S Velan; Marielle V Fortier; Keith M Godfrey; Lynette Shek; Kok Hian Tan; Peter D Gluckman; Fabian Yap; Jonathan Tze Liang Choo; Lieng Hsi Ling; Karen Tan; Li Chen; Neerja Karnani; Yap-Seng Chong; Johan G Eriksson; Mary E Wlodek; Shiao-Yng Chan; Yung Seng Lee; Navin Michael Journal: Int J Epidemiol Date: 2020-10-01 Impact factor: 7.196